This model hypothesizes that acute inflammation in early-stage DEB is driven by acute-phase reactants (e.g., CRP, IL-6, SAA) and type I cytokines (e.g., IFN-γ, TNF-α) in response to blisters, wounds, and bacterial colonization. The gene discussed is CRP; the disease is Dystrophic epidermolysis bullosa.